Pure Global AI
NCT06152055Completed

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal - A Retrospective Study
Tribhuvan University, NepalClinicalTrials.gov
Verified
Study focus
Disease/Condition
Head and Neck Cancer
Study type
Observational
Sponsor & location
Primary sponsor
Tribhuvan University, Nepal
Location
Kathmandu, Nepal
Timeline & enrollment
Phase
N/A
Start date
May 01, 2022
End date
Apr 30, 2023
Enrollment
76 participants
Primary outcome

Age - wise Distribution of Head and Neck Cancers (HNCs),: Distribution of HNCs according to subsite,Histopathology of HNCs,Tumor, Nodes, Metastasis (TNM) staging of HNC,Treatment provided to HNC patients

Summary

This is a observational study conducted at the department of Ear ,Nose and Throat -Head and
 Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal.
 Head and Neck cancers are the sixth most common cancer in the world. Data was collected from
 the medical records of Head and Neck Cancer patients who underwent treatment between May 2022
 to April 2023.The main aim of the study was to know about the common cancers of head and neck
 region and their distribution according to the site. Also to know the stage of the
 presentation with treatment modalities in the tertiary health care centre of Nepal.

ICD-10 classifications
Malignant neoplasm of other and ill-defined sites: Head, face and neckMalignant neoplasm: Skin of scalp and neckMalignant neoplasm: Connective and soft tissue of head, face and neckCarcinoma in situ: Skin of scalp and neckSecondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06152055
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06152055 through Pure Global AI's free database. This phase not specified trial is sponsored by Tribhuvan University, Nepal and is currently Completed. The study focuses on Head and Neck Cancer. Target enrollment is 76 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.